Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 5.471.992.096.266.88

What is the latest EBIT Margin ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Margin ratio of GLENMARK PHARMACEUTICALS is 5.47 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar20255.47
Mar20241.99
Mar20232.09
Mar20226.26
Mar20216.88

How is EBIT Margin of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 5.47
174.87
Mar2024 1.99
-4.78
Mar2023 2.09
-66.61
Mar2022 6.26
-9.01
Mar2021 6.88 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Margin ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,584.5 Cr 1% -8.5% 37.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1%

-8.5%

37.3%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses